Search results for: 'pfizer'
-
Musculoskeletal Collaboration and Licensing Deals 2016-2023October 2023$3,995.00
Musculoskeletal Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2023
Learn More -
Biomarker Collaboration and Licensing Deals 2016-2023November 2023$3,995.00
Biomarker Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2023
Learn More -
Diagnostic Imaging Collaboration and Licensing Deals 2016-2023November 2023$3,995.00
Diagnostic Imaging Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2023
Learn More -
Vaccine Collaboration and Licensing Deals 2016-2023November 2023$3,995.00
Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2023
Learn More -
Cardiovascular Collaboration and Licensing Deals 2016-2023April 2023$3,995.00
Cardiovascular Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2023
Learn More -
Co-development Deals in Pharmaceuticals and Biotechnology 2016-2024March 2024$3,995.00
Co-development Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More -
Gene Therapy Collaboration and Licensing Deals 2016-2023November 2023$3,995.00
Gene Therapy Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2023
Learn More -
Royalty Rates in Pharmaceutical and Biotechnology DealsMarch 2024$3,995.00
Essential Benchmark Data for Dealmakers | Global coverage | Updated to 2024 | Over a decade of royalty rates | Deal financials | Contract documents | Royalty rate trends
Learn More -
Monoclonal Antibody Collaboration and Licensing Deals 2016-2023November 2023$3,995.00
Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2023
Learn More -
Asset Purchase Deals in Pharmaceuticals and Biotechnology 2016 to 2024March 2024$3,995.00
Asset Purchase Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More